Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
Combination therapy in patients with relapsing-remitting multiple sclerosis (MS) CombiRx
Use of rituximab in multiple sclerosis: current progress and future perspectives.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
Induction of a Unique Isoform of the NCOA7 Oxidation Resistance Gene by Interferon β-1b.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Preclinical studies of sex differences: a clinical perspective.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.

Pages